13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q1 2025 · Filed May 13, 2025 · Accession 0000950123-25-004952
Total Value
$58.7M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,266,934 | $44.3M | 75.44% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $10.8M | 18.48% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $3.6M | 6.08% |